DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Dahan L, Phelip J, Malicot K, Williet N, Desrame J, Volet J. et al.
FOLFIRINOX until progression, FOLFIRINOX with maintenance treatment, or sequential treatment with gemcitabine and FOLFIRI.3 for first-line treatment of metastatic pancreatic cancer: A randomized phase II trial (PRODIGE 35-PANOPTIMOX).
J Clin Oncol 2018;
36 (suppl):abstr 4000
Access:
We do not assume any responsibility for the contents of the web pages of other providers.